Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mastercard
MA
|
+$915M |
| 2 |
Meta Platforms (Facebook)
META
|
+$693M |
| 3 |
Salesforce
CRM
|
+$618M |
| 4 |
Walt Disney
DIS
|
+$559M |
| 5 |
Nike
NKE
|
+$545M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$1.51B |
| 2 |
Pfizer
PFE
|
+$1.43B |
| 3 |
UBS Group
UBS
|
+$588M |
| 4 |
HSBC
HSBC
|
+$537M |
| 5 |
Procter & Gamble
PG
|
+$439M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.07% |
| 2 | Consumer Discretionary | 10.99% |
| 3 | Financials | 10.93% |
| 4 | Healthcare | 10.39% |
| 5 | Communication Services | 6.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
$18.6B
| $481K | ﹤0.01% |
8,753
+412
| +5% | +$23.8K |
|
552
iShares Core MSCI Emerging Markets ETF
IEMG
$156B
| $475K | ﹤0.01% |
11,740
-5,534
| -32% | -$272K |
|
553
VeriSign
VRSN
$26.6B
| $474K | ﹤0.01% |
2,631
+56
| +2% | +$11K |
|
554
Broadcom
AVGO
$2.04T
| $473K | ﹤0.01% |
19,950
+480
| +2% | +$13.5K |
|
555
Vanguard Short-Term Bond ETF
BSV
$44.6B
| $471K | ﹤0.01% |
5,732
+2,858
| +99% | +$232K |
|
556
EPAM Systems
EPAM
$5.09B
| $470K | ﹤0.01% |
2,532
+175
| +7% | +$37.8K |
|
|
PE
557
DELISTED
PARSLEY ENERGY INC
PE
| $463K | ﹤0.01% |
80,833
-1,389
| -2% | -$18.8K |
|
558
Smith & Nephew
SNN
$12.6B
| $462K | ﹤0.01% |
12,874
-3,208
| -20% | -$142K |
|
559
iShares Core MSCI EAFE ETF
IEFA
$196B
| $461K | ﹤0.01% |
9,249
-29,377
| -76% | -$1.75M |
|
560
Ford
F
$55.7B
| $452K | ﹤0.01% |
93,483
+21,521
| +30% | +$161K |
|
561
iShares Global Consumer Discretionary ETF
RXI
$278M
| $452K | ﹤0.01% |
+4,779
| New | +$553K |
|
562
NextEra Energy
NEE
$177B
| $445K | ﹤0.01% |
7,388
+988
| +15% | +$62.1K |
|
563
iShares 0-5 Year High Yield Corporate Bond ETF
SHYG
$7.62B
| $440K | ﹤0.01% |
10,766
-223
| -2% | -$9.99K |
|
564
Phillips 66
PSX
$81.4B
| $438K | ﹤0.01% |
8,170
+1,218
| +18% | +$99.1K |
|
565
iShares Russell 2000 ETF
IWM
$83B
| $429K | ﹤0.01% |
3,752
-1,903
| -34% | -$284K |
|
566
Vanguard Tax-Exempt Bond Index Fund
VTEB
$45.3B
| $424K | ﹤0.01% |
8,013
-45
| -0.6% | -$2.41K |
|
567
Fidelity MSCI Health Care Index ETF
FHLC
$3.36B
| $423K | ﹤0.01% |
9,833
+462
| +5% | +$21.9K |
|
568
Eagle Bancorp
EGBN
$845M
| $422K | ﹤0.01% |
13,982
-33,776
| -71% | -$1.36M |
|
569
Fidelity Nasdaq Composite Index ETF
ONEQ
$10.9B
| $420K | ﹤0.01% |
14,060
-9,400
| -40% | -$321K |
|
570
SPDR Gold Trust
GLD
$141B
| $416K | ﹤0.01% |
2,813
+1,136
| +68% | +$169K |
|
571
iShares Russell 1000 Value ETF
IWD
$83.7B
| $410K | ﹤0.01% |
4,131
+2,070
| +100% | +$258K |
|
572
American Electric Power
AEP
$68.4B
| $406K | ﹤0.01% |
5,082
+2,851
| +128% | +$270K |
|
573
Wabtec
WAB
$49.3B
| $404K | ﹤0.01% |
8,400
-418
| -5% | -$28.7K |
|
574
Tesla
TSLA
$1.3T
| $400K | ﹤0.01% |
11,460
+2,250
| +24% | +$93.3K |
|
|
PGNX
575
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $399K | ﹤0.01% |
105,125
| – | – |
|
Similar funds
Ken Fisher's Q1 2020 Portfolio in Review
As of Q1 2020, Ken Fisher held 982 positions worth $80.6B, down 19% from $99B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Fisher's Q1 2020 filing shows 84 new, 262 increased, 421 reduced and 116 closed positions. Its largest new stake was Advanced Micro Devices: 7,132,669 shares worth $324M. The largest sale was Johnson & Johnson, an estimated $1.51B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Financials.
- Ken Fisher's largest Q1 2020 buy was Advanced Micro Devices: 7,132,669 shares worth $324M.
- Ken Fisher added most to Mastercard in Q1 2020, an estimated $915M increase.
- Ken Fisher's biggest Q1 2020 reduction was Johnson & Johnson, cutting an estimated $1.51B.
- Ken Fisher fully exited Ambev in Q1 2020, selling an estimated $89.9M.
- Ken Fisher's ten largest holdings make up 31% of its $80.6B portfolio in Q1 2020.
- Ken Fisher opened 84 new positions and closed 116 in Q1 2020.
- Ken Fisher's portfolio value fell 19% quarter-over-quarter to $80.6B.
Based on Fisher Asset Management's 13F filing for Q1 2020, filed 28 Apr 2020.